Hand, foot, and mouth disease is usually mild, but serious complications can occur. At #AAP2026, Hai D. Nguyen-Tran, MD, highlighted warning signs, hydration strategies, and prevention tips pediatricians should know. Read more: contemporarypediatrics.com/v… #Pediatrics #HFMD

The FDA accepted the resubmitted NDA for dibutepinephrine (Anaphylm) sublingual film and set a PDUFA date of March 16, 2027. If approved, it would be the first oral epinephrine option for anaphylaxis in patients ≥30 kg. hubs.li/Q04Bgwfs0

Behind the scenes at #AAP2026! 🎥 Our editors recently connected with leading experts in San Diego to discuss the latest research, clinical updates, and takeaways for pediatricians. Take a look at our interviews and stay tuned for more coverage! hubs.li/Q04Bc7YN0

Trust alone may not be enough to overcome health misinformation. At #AAP2026, Todd Wolynn, MD, discussed why pediatricians need to go beyond data and connect with families through empathy, listening, and effective communication. hubs.li/Q04B3tMb0

A teenage athlete's cardiac arrest during a track event revealed a rare inherited heart rhythm disorder affecting 3 generations of her family. Explore the importance of recognizing warning signs, genetic screening, and early intervention: hubs.li/Q04zXXK00

Intentional substance exposures at school rose 287% among children aged 6–10 years from 2000 to 2024. Gary A. Smith, MD, DrPH, of @nationwidekids, emphasizes the need for earlier prevention and mental health screening. hubs.li/Q04zXV3C0

When evaluating a child's rash, the history may be the most important diagnostic tool. At #AAP2026, Peter Lio, MD, discussed differentiating eczema, food reactions, drug eruptions, and other common skin conditions. Read more: hubs.li/Q04zP99q0

The FDA has approved dolutegravir for eligible newborns with HIV weighing at least 2 kg. IMPAACT 2023 lead investigator Diana F. Clarke, PharmD, explains the data, the newborn dosing and what’s still unknown for preterm infants. hubs.li/Q04zH3zt0

Increasing maternal egg and peanut intake during pregnancy and breastfeeding did not prevent food allergy in high-risk infants, according to the PrEggNut trial. At age 1, egg or peanut allergy occurred in 7.8% vs 8.4% of infants. Read more: hubs.li/Q04zxDTd0

At #AAP2026, Carmen Tong, DO, discussed bladder-bowel dysfunction, behavioral management, and when pediatricians should consider a urology referral. hubs.li/Q04z7LwY0

Most young patients with sporadic colorectal cancer in a multicenter study presented with stage III or IV disease, highlighting the importance of recognizing persistent GI symptoms in adolescents. #AAP2026 Read more: hubs.li/Q04z6m3G0

Not every child with a sore throat needs a strep test. At #AAP2026, Rana Hamdy, MD, @ChildrensNatl, discussed how targeted testing, appropriate antibiotic selection, and practice workflows can reduce unnecessary treatment for group A strep. hubs.li/Q04z5T_c0

At #AAP2026, researchers found just 21.5% of 65 health organizations posted on Instagram addressing claims linking prenatal acetaminophen use with autism during a period of heightened attention in 2025. hubs.li/Q04z5PKn0

We're on-site at #AAP2026 covering hot topics in pediatrics and interviewing the leading experts in the speciality. Check back often on our social channels and hubs.li/Q04z5Pxw0 for the latest from the AAP 2026 National Conference & Exhibition.

The FDA has approved the Autus Size-Adjustable Valve, the first heart valve designed to expand as a child grows. Read more: hubs.li/Q04yZxdh0

Heading to #AAP2026? From generative AI and health misinformation to vaccines, type 1 diabetes, nutrition, and behavioral health, this year’s agenda tackles key issues in pediatric practice. See what’s ahead: hubs.li/Q04yXmjn0

The FDA approval of #Camzyos gives adolescents with symptomatic obstructive HCM a disease-targeted treatment option. Joseph Rossano, MD, discusses what the approval means for pediatric cardiologists and their patients: hubs.li/Q04yQMT30

🚨BREAKING: The FDA has approved Camzyos (mavacamten) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy in adolescents. Read more about the approval and the study findings that supported the decision here: hubs.li/Q04yQK1m0

Can you diagnose this 16-month-old? 🔎 A worsening rash progressed to pustules after treatment for otitis media. What’s your diagnosis? Take the poll: hubs.li/Q04yJ-s80 Answer revealed Oct. 1 at noon ET.

DBV has filed a BLA for the Viaskin peanut patch in kids aged 4-7 with peanut allergy. In phase 3 VITESSE, 46.6% of children on the patch met responder criteria vs 14.8% on placebo at 12 months. Priority review has been requested. hubs.li/Q04yJPfD0